# The Study of Biomarker in Early Diagnosis of GDM by Metabolomics

> **NCT05733195** · — · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Gestational Diabetes Mellitus
- Metabolomics Detection
- Biomarker in Early Diagnosis

## Interventions

- **OTHER:** OGTT test

## Key facts

- **NCT ID:** NCT05733195
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-04
- **Primary completion:** 2023-08-30
- **Final completion:** 2024-05-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05733195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05733195, "The Study of Biomarker in Early Diagnosis of GDM by Metabolomics". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05733195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*